
Hosted by Fertility Bridge · EN

Third-party IVF is getting bigger, but are clinics actually getting better at it?Or are some efforts to streamline the process creating new risks for patients?Dr. Allison Bloom of Main Line Fertility and Dr. Daniel Shapiro of Reproductive Biology Associates (RBA) discuss what separates a clinic that offers third-party reproduction from one that truly excels at it.We dive into:The push to streamline third-party IVF (and where corners may be getting cut)The technology stack donor & surrogacy programs needThe gaps in today’s EMRs and what needs to changeEmerging trends around known donorsNew thinking on anonymous vs. de-identified donationOne thing each physician believes clinics should start (or stop) doing to become a third-party IVF powerhouseAs third-party reproduction becomes more common, the operational, ethical, and technological challenges become harder to ignore.

More than half of IVF patients never complete treatment. Stress, finances, and relationship strain may play a role, but are fertility workflows optimized for cycles completed over families built also to blame?In this episode, leaders from Inception Fertility share how they’re using technology, workflow design, and operational strategy to improve the patient journey from first inquiry through graduation.What Inception uncovered by integrating their EMR with SalesforceInsights into no-shows and cancellations from patient data analysisWorkflow improvements being implemented across staff and physiciansHow to evaluate which solutions can scale network-wideThe build vs. buy debate around automation & moreHow much friction still exists in your patient journey, and where could better systems make the biggest difference?

Cyber threats in fertility aren’t abstract, they're active and closer than most clinics think.And with AI lowering the barrier, even inexperienced actors can cause serious damage.In this episode of Inside Reproductive Health, One Stop IT experts Chris Diamond and Jordan Spriegel share what’s really happening and how fertility centers can respond.How cyber attackers infiltrate fertility and OBGYN systemsWhy these threats aren’t limited to large healthcare organizationsWhat clinics should be doing now to protect their systems and patientsThe right and wrong way to approach EMR migrationWhere AI is already being used in fertility practices todayHow prepared is your clinic for this level of threat?

Genetic testing in IVF is only getting more complex and more common. REIs, you’re not supposed to do this alone, help is already here.We speak with four genetic counselors, Amber Kaplun, Rachel Donnell, Andria Besser, and Lauri Black, about how this works in practice.We dive into:How to embed genetic counselors into your workflowHow to free up REI time while improving patient experienceWhy access to genetic counselors isn’t as limited as it seemsHow third-party services like GeneScreen fit into clinical operationsTheir perspective on PGT-P vs. PGT-G (and where the field is heading)

What is CCRM building toward, and how are they preparing for what comes next? As part of Unified Women’s Healthcare, CCRM is positioning for a future where “hub and spoke” becomes more than just a buzzword. Tracy Belsan, President of CCRM Fertility, joins the episode to share how they’re thinking about growth, operations, and the patient journey.We dive into:The KPIs CCRM focuses onThe operational barrier they removed (Moving patients into care faster)How technology is being implemented across the patient journeyCCRM’s approach to patient finance and access to careThe role of APPs and evolving clinical modelsWhat it takes to consolidate an entire network onto a single EMR by 2027

A tale of two PGTs.One is making bold promises and headlines, the other is quietly gaining traction and relevance.Between PGT-P & PGT-G…what’s actually moving the needle?Dr. Mili Thakur of Genome Ally and Dr. Sasha Hakman of HRC Fertility break down what they’re seeing in real patients, especially when everything else has already failed.We dive into:The real difference between PGT-P and PGT-GWhy some genetic claims are under scrutinyWhere whole genome sequencing is actually helpingHow PGT-G may reduce repeated failed IVF cyclesWhether this can truly shorten time to pregnancy

The results are in: 5 healthy babies born, 64.3% fertilization rate, zero eggs damaged across hundreds of oocytes.Lab automation in IVF is no longer theoretical, it’s been proven.Chief Scientific Officers Jason Barritt of Kindbody and Jacques Cohen of Conceivable Life Sciences join the episode to discuss a recent study published in Human Reproduction examining AURA, the robotic lab system developed by Conceivable Life Sciences.We dive into:What “proof of concept” actually means in IVF lab automationWhy this study matters (And where it falls short of current standards)The role of automation as a testing ground for new lab technologiesWhat a fully automated IVF lab could unlockWhether “hub and spoke” models in fertility have been misunderstood (and what they could actually become)If automation continues to progress, the scale of what’s possible in fertility care may look very different than it does today.

Do fertility doctors deserve happiness?It sounds like a strange question, but for many REIs it’s not abstract.We step back from operations, technology, and finance to ask a more fundamental question with Inception’s National Medical Director, Dr. Jason Yeh:What does a good life actually look like for a fertility specialist?In this conversation, we explore:Moral injury vs. burnoutThe X–Y axis of time and money in a physician’s careerHappiness vs. meaningWhy fertility doctors often benchmark happiness against the status and performance of peersLiving in the moment as an REIThe different kinds of regret fertility doctors describe at the end of their careersConversations like this are rare. If you find value in it, please tell us. Because if the field wants more conversations like this, we need to prove they’re worth having.

What are the drug makers up to?And who’s about to win or lose in fertility pharmacy?This final category overview takes a hard look at the shifting pharmaceutical landscape of legacy manufacturers, rising challengers, supplement disruptors, and the latest in professional services.We also dive into:Why the pharmacy “middle” may be hollowed outWhich models are positioned to scale (and which aren’t)Who operators are calling when they need expert guidanceThe consultants and firms quietly shaping growth behind the scenesDive deeper into any of these topics through our Inside Reproductive Health Digest Articles:Pharmacy, Pharmaceuticals, Professional Services, Supplements

Patients want clearer pricing, clinics want operational sustainability, managed care wants predictable cost control……and everyone wants more transparency.This epiosde centers on the groundbreaking Journal of Assisted Reproduction and Genetics (JARG) paper on Activity-Based Costing in IVF and what it actually costs.We’re joined by Pinnacle CFO Shruti Sood, The Fertility Partners CEO Heather Stark, and Chartis Partner Bret Anderson to discuss:Why IVF costs have not been accurately accounted forHow activity-based costing could reshape pricing modelsThe real impact of payer consolidationWhere clinics confuse capacity problems with volume problemsWhether different prognosis patients should be priced differentlyHow managed care pressure will change IVF economics